tbuckley/cabot-search huggingface dataset:
Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study
Authors: Tom G Richardson, Eleanor Sanderson, Benjamin Elsworth, Kate Tilling, George Davey Smith
Journal: BMJ (2020)

To evaluate whether body size in early life has an independent effect on risk of disease in later life or whether its influence is mediated by body size in adulthood.Two sample univariable and multivariable mendelian randomisation.The UK Biobank prospective cohort study and four large scale genome-wide association studies (GWAS) consortiums.453 169 participants enrolled in UK Biobank and a combined total of more than 700 000 people from different GWAS consortiums.Measured body mass index during adulthood (mean age 56.5) and self-reported perceived body size at age 10.Coronary artery disease, type 2 diabetes, breast cancer, and prostate cancer.Having a larger genetically predicted body size in early life was associated with an increased odds of coronary artery disease (odds ratio 1.49 for each change in body size category unless stated otherwise, 95% confidence interval 1.33 to 1.68) and type 2 diabetes (2.32, 1.76 to 3.05) based on univariable mendelian randomisation analyses. However, little evidence was found of a direct effect (ie, not through adult body size) based on multivariable mendelian randomisation estimates (coronary artery disease: 1.02, 0.86 to 1.22; type 2 diabetes:1.16, 0.74 to 1.82). In the multivariable mendelian randomisation analysis of breast cancer risk, strong evidence was found of a protective direct effect for larger body size in early life (0.59, 0.50 to 0.71), with less evidence of a direct effect of adult body size on this outcome (1.08, 0.93 to 1.27). Including age at menarche as an additional exposure provided weak evidence of a total causal effect (univariable mendelian randomisation odds ratio 0.98, 95% confidence interval 0.91 to 1.06) but strong evidence of a direct causal effect, independent of early life and adult body size (multivariable mendelian randomisation odds ratio 0.90, 0.85 to 0.95). No strong evidence was found of a causal effect of either early or later life measures on prostate cancer (early life body size odds ratio 1.06, 95% confidence interval 0.81 to 1.40; adult body size 0.87, 0.70 to 1.08).The findings suggest that the positive association between body size in childhood and risk of coronary artery disease and type 2 diabetes in adulthood can be attributed to individuals remaining large into later life. However, having a smaller body size during childhood might increase the risk of breast cancer regardless of body size in adulthood, with timing of puberty also putatively playing a role.
STENT EXPANSION MODELS TO PREDICT CLINICAL OUTCOME: AN IVUS SUBSTUDY FROM ADAPT-DES
Authors: Tatsuhiro Fujimura, Mitsuaki Matsumura, Bernhard Witzenbichler, David C. Metzger, Michael Rinaldi, Peter L. Duffy, Giora Weisz, Thomas D. Stuckey, Ziad Ali, Aaron Crowley, Gary Mintz, Gregg Stone, Akiko Maehara
Journal: Journal of the American College of Cardiology (2020)
SEX-BASED DIFFERENCES ON LEFT VENTRICULAR REMODELING AND SURVIVAL IN PATIENTS WITH CHRONIC AORTIC REGURGITATION: IS THERE A NEED FOR SEX SPECIFIC THRESHOLDS FOR SURGICAL INTERVENTION?
Authors: Isadora Sande Mathias, Albree Tower-Rader, Yash Kumar, Duygu Kocyigit, Nancy Obuchowski, Zoran Popovic, Dermot Phelan, Eoin Donnellan, Michael Bolen, Scott D. Flamm, Brian P. Griffin, Leslie Cho, Gosta Pettersson, Deborah Kwon
Journal: Journal of the American College of Cardiology (2020)
LIPOPROTEIN (A) AND CARDIOVASCULAR MORTALITY IN OLDEST OLD (≥80 YEARS) PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A OBSERVATIONAL STUDY ON 1008 CASES
Authors: Meng Zhang, Jing-Lu Jin, Xiao-Ni Yan, Qian Dong, Ye-Xuan Cao, Hui-Hui Liu, Jian-Jun Li
Journal: Journal of the American College of Cardiology (2020)
Abstract ES4-2: Single cell transcriptomics reveals multi-step adaptations to endocrine therapy
Authors: L Magnani, I Barozzi, S Hong
Journal: Cancer Research (2020)

Abstract Resistant tumours are thought to arise from the action of Darwinian selection on genetically heterogenous cancer cell populations. However, simple clonal selection is inadequate to describe the late relapses often characterising luminal breast cancers treated with endocrine therapy (ET), suggesting a more complex interplay between genetic and non-genetic factors. During this talk, I will briefly introduce a series of molecular tools that can be used to study transcriptional changes at the single cell level in relevant models. I will then show how used these tools to dissect the contributions of clonal genetic diversity and transcriptional plasticity during the early and late phases of ET at single-cell resolution. Using single-cell RNA-sequencing and imaging we could disentangle the transcriptional variability of plastic cells and define a rare subpopulation of pre-adapted (PA) cells which undergoes further transcriptomic reprogramming and copy number changes to acquire full resistance. We find evidence for sub-clonal expression of a PA signature in primary tumours and for dominant expression in clustered circulating tumour cells. I will then update the audience on how it is possible to integrate these technologies directly into clinical studies and what developments are happening in the field of single cell technologies. I will finally propose a multi-step model for ET resistance development and advocate the use of stage-specific biomarkers. Citation Format: L Magnani, I Barozzi, S Hong. Single cell transcriptomics reveals multi-step adaptations to endocrine therapy [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr ES4-2.
What information do patients need about their disease or treatments and what they want for end of life?
Authors: Gaston Martin Reinas, Ernesto Gil Deza, Eduardo L. Morgenfeld, Daniela Gercovich, Flavio Tognelli, Natasha Gercovich, Monica Montiel, Carlos Fernando Garcia Gerardi, Edgardo G. J. Rivarola, Felipe G. Gercovich
Journal: Journal of Clinical Oncology (2013)

e20656 Background: As it is very important for Doctors, Patients (Pt) and Family to know everything related to end of life we thought it was unavoidable to develop a survey for that purpose. Methods: Between Oct 15th and Nov 15th, 2012, 1003 Pt out of 3795 Pt that were assisted at the IOHM were given the option to participate in an anonymous survey about diagnosis, prognosis, efficacy and toxicity of treatments, as well as interest in palliative care (PC), clinical investigation (CI), psychological support (PS), spiritual care (SC) for an eventual situation of coping with the end of life dilemma. Results: A total of 845 out of 1,003 (84%) Pt elected to participate. Population: Sex: fem: 332, male: 207, left blank (LB): 306. Mean age 58y (range 18 – 94). Married: 355, unmarried: 211, LB: 279. Children Yes 460 No/LB: 385. Highest educational level achieved: primary Studies:186, high School: 348, universitary:216. LB: 98. Employed:382, retired: 240, unemployed: 112, LB 111. Disclosed diagnostic and stage of disease: 470 (56%). The following results are expressed as a percentage of 845 pt: Are aware of the diagnostic (82%); Pt interested in knowing everythingabout their prognosis (85%) or their treatment’s efficacy (67%) or toxicity (52%). Pt interested in: PC (85%), CI (80%), PS (74%), SC (58%). If they were to choose a place for dying: 40% chose to die in the hospital, 30% at home, 29% did not answer and 1% was indifferent. It was possible to detect a marked increase in the amount of answers with regards to last wishes as the stage of the disease worsened (Chi square= 0.011). Pt were asked to rate the survey: 95% considered it good or very Good, 56% found it useful, 36% thought it necessary, while 23% would recommend it. Conclusions: 1) Most of the pt know their diagnosis, would like to know their prognosis and need to know everything about efficacy and toxicity of treatments. 2) 40% of the pt would prefer to die in the hospital, but analyzing this choice at earlier stages of disease may be inappropriate. 3) PC and CI are of interest to both sexes but women are more likely to request PS and SC. 4) Although the survey was considered good by 95% of pt and more than 50% found it useful, only 23% would recommend it, which speaks about the sensitive quality of these topics.
DECREASE IN ABSOLUTE LYMPHOCYTE COUNT IN IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS
Authors: Zsofia Drobni, Amna Zafar, Daniel Zlotoff, Leyre Zubiri, Raza Alvi, Lili Zhang, Adam Rokicki, Anju Nohria, Alexandra-Chloé Villani, John Groarke, Ryan J. Sullivan, Kerry L. Reynolds, Tom Neilan
Journal: Journal of the American College of Cardiology (2020)
MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis
Authors: Chien-Kuang Cornelia Ding, Joshua Rose, Tianai Sun, Jianli Wu, Po-Han Chen, Chao-Chieh Lin, Wen-Hsuan Yang, Kai-Yuan Chen, Hana Lee, Emily Xu, Sarah Tian, Jadesola Akinwuntan, Jinshi Zhao, Ziqiang Guan, Pei Zhou, Jen-Tsan Chi
Journal: Nature Metabolism (2020)
Strontium modulates osteogenic activity of bone cement composed of bioactive borosilicate glass particles by activating Wnt/β-catenin signaling pathway
Authors: Xu Cui, Yadong Zhang, Jianyun Wang, Chengcheng Huang, Yudong Wang, Hongsheng Yang, Wenlong Liu, Ting Wang, Deping Wang, Guocheng Wang, Changshun Ruan, Dafu Chen, William W. Lu, Wenhai Huang, Mohamed N. Rahaman, Haobo Pan
Journal: Bioactive Materials (2020)

There is a need for synthetic grafts to reconstruct large bone defects using minimal invasive surgery. Our previous study showed that incorporation of Sr into bioactive borate glass cement enhanced the osteogenic capacity in vivo. However, the amount of Sr in the cement to provide an optimal combination of physicochemical properties and capacity to stimulate bone regeneration and the underlying molecular mechanism of this stimulation is yet to be determined. In this study, bone cements composed of bioactive borosilicate glass particles substituted with varying amounts of Sr (0 mol% to 12 mol% SrO) were created and evaluated in vitro and in vivo. The setting time of the cement increased with Sr substitution of the glass. Upon immersion in PBS, the cement degraded and converted more slowly to HA (hydroxyapatite) with increasing Sr substitution. The released Sr2+ modulated the proliferation, differentiation, and mineralization of hBMSCs (human bone marrow mesenchymal stem cells) in vitro. Osteogenic characteristics were optimally enhanced with cement (designated BG6Sr) composed of particles substituted with 6mol% SrO. When implanted in rabbit femoral condyle defects, BG6Sr cement supported better peri-implant bone formation and bone-implant contact, comparing to cements substituted with 0mol% or 9mol% SrO. The underlying mechanism is involved in the activation of Wnt/β-catenin signaling pathway in osteogenic differentiation of hBMSCs. These results indicate that BG6Sr cement has a promising combination of physicochemical properties and biological performance for minimally invasive healing of bone defects.
Influence of extracapsular extension on lymph node staging for patients with squamous cell carcinoma of the head and neck.
Authors: Megan Ann Baumgart, Carlos Rodrigo Acevedo-Gadea, Zuoheng Wang, Eugenia Buta, Marianne Davies, Hari Anant Deshpande, Roy H. Decker, Clarence Sasaki, Benjamin Judson, Roy S. Herbst, Daniel Morgensztern
Journal: Journal of Clinical Oncology (2012)

5532 Background: Although extracapsular extension (ECE) is a known poor prognostic factor in head and neck squamous cell carcinoma (HNSCC) and recommended to be collected by the current AJCC manual, it currently does not influence the final stage. We evaluated the prognostic impact of ECE in 4 primary sites. Methods: The Surveillance Epidemiology and End Results (SEER) was queried for patients with squamous cell cancers of the oral cavity (OC), oropharynx (OP), hypopharynx (H) and larynx (L), known ECE status, M0, and diagnosed between 2004 and 2007. Survival curves were estimated by the Kaplan-Meier and compared by Cox proportional hazards models. Results: There were 23,384 patients meeting eligibility criteria, including 14,664 (62.7%) N0, 6483 (27.7%) N+ without ECE (NECE), and 2237 (9.6%) with ECE. ECE was associated with decreased 3-year overall survival (OS), compared to NECE, for all lymph node stages including N1 (52% vs 61%, HR 1.32, p = 0.001), N2a (60% vs 76%, HR 1.82, p&lt;0.001), N2b (44% vs 62%, HR 1.62, p&lt;0.001), N2c (34% vs 47%, HR 1.43, p&lt;0.001), N3 (31% vs 44%, HR 1.38, p=0.012). ECE was also an independent poor prognostic factor for cancer in the OC (HR 1.43, p &lt; 0.001), OP (HR 1.44, p &lt; 0.001), H (HR 1.58, p = 0.01), and L (HR 1.28, p = 0.01). The comparison between ECE and NECE with one additional N degree showed no significant OS difference, except OP N1 and H N2a ECE, where survival was inferior to OP N2a and H N2b NECE respectively (Table). Conclusions: ECE is a significant predictor for poor outcomes in HNSCC, with survival equivalent to one additional degree of N involvement. [Table: see text]
PLATELET AND MONOCYTE ACTIVATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (POTENT-TAVR): A RANDOMIZED CONTROLLED TRIAL OF TICAGRELOR VERSUS CLOPIDOGREL BEFORE TAVR
Authors: David Alexander Zidar, Sadeer Al-Kindi, Anthony Main, Michael Osnard, Nour Tashtish, Sahil Parikh, Nicholas Funderburg, Steven Juchnowski, Christopher Longenecker, Trevor Jenkins, Christopher Nmai, Curtis Tatsuoka, Marco Costa, Eugene Blackstone, Michael Lederman, Guilherme Attizzani, Daniel I. Simon
Journal: Journal of the American College of Cardiology (2020)
Development of a surgical assessment tool for national policy monitoring &amp; evaluation in Ethiopia: A quality improvement study
Authors: K.R. Iverson, O. Ahearn, I. Citron, K. Garringer, S. Mukhodpadhyay, A. Teshome, A. Bekele, S. Workneh, R.S. Workneh, S. Zemenfeskudus, T. Gultie, A. Varghese, M.G. Shrime, J.G. Meara, D. Burssa
Journal: International Journal of Surgery (2020)
The role of systemic and cranial <sup>18</sup>Fluorodeoxyglucose positron emission tomography (FDG PET) in primary central nervous system lymphoma (PCNSL)
Authors: N. A. Mohile, L. M. Deangelis, L. E. Abrey
Journal: Journal of Clinical Oncology (2006)

1535 Background: The utility of body and brain FDG PET in staging and management of PCNSL is unknown. Methods: We performed a retrospective study of 166 PCNSL pts at Memorial Sloan-Kettering Cancer Center between January 2000 and August 2005. Pts. who underwent PET imaging were identified using the electronic medical record. PET reports and clinical data were reviewed to determine the reason for the study and impact on management. Results: 61 (37%) pts had ≥1 PET scans. Of 93 studies, 58 were body scans and 35 were brain scans. 72% (42/58) of body PET were done for systemic staging at diagnosis and 28% (16/58) at relapse. 19% (8/42) of scans done for initial staging had suspicious systemic foci. Lymphoma was found in 3 (37.5%), adrenal adenoma in 1 (12.5%), duodenal adenocarcinoma in 1 (12.5%) and non-diagnostic tissue in 1 (12.5%); biopsy was not pursued in 2 (25%). 31% (5/16) of scans done at relapse were abnormal. In 3 (19%) of these, biopsy revealed lymphoma; in 2 (12.5%), biopsy was not pursued. In 8% (4/50) of pts (SUV 12.8, 14.3, 22, 30.5), PET was the only study to demonstrate systemic lymphoma. 2 other pts found to have systemic disease had suspicious findings on conventional imaging in addition to positive body PET (SUV 3.8, 4.1). 43% (15/35) of brain PET were done at diagnosis and 57% (20/35) were done to evaluate residual MRI abnormalities after treatment. 14 brain PET at diagnosis were positive; SUV reported in 7 of these pts ranged from 7.5 to 26.8. The pt with a negative PET was receiving steroids. 10 brain PET done after treatment showed residual tumor and affected interpretation of MRI response. SUV reported in 7 of these pts. ranged from 8.1 to 29. Conclusions: Body PET imaging appears to be a sensitive tool for the detection of occult systemic lymphoma that may be missed with other diagnostics. While Brain PET at initial diagnosis did not yield incremental information, it may be useful in the interpretation of persistent MRI abnormalities after treatment. No significant financial relationships to disclose.
SHARED CARE: A NOVEL APPROACH TO LEFT VENTRICULAR ASSIST DEVICE (LVAD) IMPLANT FOLLOW UP
Authors: Ganesh Gajanan, Kulpreet Barn, Jerome Thomas, Mauricio Garrido, Rohinton Morris, Therese Prentice, Maureen Hummel, Kevin Hagan, Donald Haas
Journal: Journal of the American College of Cardiology (2020)
Abstract 10960: Red Cell Distribution Width and Mortality in Cardiorenal Anemia Syndrome
Authors: Yu Lun Cheng
Journal: Circulation (2015)

Introduction: The interaction between heart failure, renal insufficiency and anemia has been termed as cardiorenal anemia (CRA) syndrome. Red cell distribution width (RDW) hasn’t been clarified of the prognostic impacts in acute heart failure (HF) with cardiorenal anemia syndrome. Hypothesis: RDW remained its prognostic predictive power in patient with cardiorenal anemia syndrome Methods: A total of 978 patients (age 75±14 years, 70% men) hospitalized for AHF were enrolled. National Death Registry was linked for the clinical outcomes of all-cause mortality. We collected data of past medical history, biochemistry profiles, and echocardiographic on admission. Results: Among the study population, 419 (43%) subjects had cardiorenal anemia syndrome. Across the tertiles of RDW distribution, high RDW was associated with lower left ventricular ejection fraction (LVEF) and hemoglobin levels, and higher serum creatinine levels. During a median follow-up duration of 31 months, 472 subjects (43%) died. The post-discharge mortality increased along with the tertiles of RDW(Figure). After accounting for age, gender, co-morbidities, hemoglobin, renal function, and sodium level, RDW remained an independent predictor of mortality (HR and 95% CI for 1% increase of RDW: 1.11; 1.07-1.15). With further adjustment of NT-proBNP, RDW still was an independent prognostic factor. With adjustments for age, sex and hemoglobin in subgroup analysis, RDW was associated with mortality in patients with chronic kidney disease stage I/II (1.09; 1.03-1.15), III (1.12; 1.06-1.19), and IV/V (1.07; 1.00-1.14). Furthermore, in patients with CRA syndrome, RDW was still related to mortality (1.07; 1.02-1.12). Conclusions: Elevated RDW is independently associated with mortality in patients hospitalized for acute HF, despite anemia status, renal function, or CRA syndrome status. Giving RDW an easily accessible marker, the study results may support RDW to improve the risk stratification of acute HF.
SHOULD WE REINTRODUCE PREVIOUS VENOUS THROMBOEMBOLISM INTO DECISION-MAKING FOR ANTICOAGULATION IN ATRIAL FIBRILLATION? A NATIONWIDE COHORT STUDY
Authors: Thure Overvad, Flemming Skjøth, Ida Ehlers Albertsen, Torben B. Larsen, Mette Søgaard, Gregory Lip
Journal: Journal of the American College of Cardiology (2020)
RELATIONSHIP OF PHYSICAL FITNESS AND METABOLIC SYNDROME TO 10-YEAR MORTALITY IN WOMEN: A REPORT FROM THE WOMEN's ISCHEMIA SYNDROME EVALUATION STUDY
Authors: Odayme Quesada, Janet Wei, Nissi Suppogu, Galen Cook-Wiens, Marie Lauzon, Steven Reis, Leslee J. Shaw, George Sopko, Eileen Handberg, Carl J. Pepine, C. Noel Bairey Merz
Journal: Journal of the American College of Cardiology (2020)
Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020
Authors: Nadim Cassir, Laurence Pascal, David Ferrieux, Christiane Bruel, Christophe Guervilly, Stanislas Rebaudet, Kostas Danis, Lora Kopec, Florence Fenollar, Emmanuelle Varon, Véronique Vig, Jean-Luc Lasalle, Lauriane Ramalli, Pierre Michelet, Jean-Christophe Lagier, Nicolas Persico, Philippe Brouqui, Philippe Malfait, Philippe Parola
Journal: Eurosurveillance (2020)

We report the third outbreak of pneumococcal pneumonia within one year among workers in European shipyards. During January and February 2020, 37 cases of pneumonia were identified in a shipyard in Marseille, south-eastern France. Outbreak control measures were implemented, including a mass vaccination campaign with 23-valent pneumococcal polysaccharide vaccine targeting all shipyard workers. Given the high mobility of shipyard workers, coordinated responses between European public health institutes are necessary to avoid further outbreaks.
Racial disparity in incidence and survival for gastrointestinal stromal tumors (GIST): An analysis of SEER database.
Authors: Mark Bilinyi Ulanja, Mohit Rishi, Bryce Beutler, Kenneth Konam, Mokshya Sharma, Santhosh Ambika, Nageshwara Gullapalli, Tomas Hinojosa
Journal: Journal of Clinical Oncology (2019)

11037 Background: Gastrointestinal tumors (GISTs) represent the most common mesenchymal tumors of the gastrointestinal tract. There has been limited data on GISTs incidence and survival disparities between ethnic groups. We assess disparities in incidence and survival among race in the United States in the era of available GIST histologic codes and treatment. Methods: We queried Surveillance, Epidemiology, and End Results (SEER) database for GIST from 2002 to 2015, with diagnostic code 8936. Results: Of the 7,204 patients identified, 4,928 (68.4%) were White; 1,308 (18.2%) African American (AA) and 968 (13.4%) were classified as Other (American Indian/Alaskan Native, Asian/Pacific Islander). The overall incidence rate (IR) was 0.753 per 100,000. IR was highest among AA at 1.372/100,000, but 0.648/100,000 for Whites, 1.075/100,000 for Asians/Pacific Islanders and 0.276/100,000 for American Indians/Alaskan Natives. The GIST incidence was twice as high for AA as for Whites (Rate ratio [RR]: 2.12; 95% CI: 1.98-2.26; p&lt;0.001). Lower proportion of AA underwent surgery as compared to white and Other. Median overall survival (OS) [116 months] and GIST specific survival (GSS) was significantly lower in AA as compared to White and Other. In multivariate Cox model, belonging to Other had better OS (adjusted hazard ratio [aHR]; 0.81, 95% CI: 0.69-0.95, P=0.011) for GIST, but no difference in prognosis and OS for AA and White [(aHR for whites; 0.93, 95% CI: 0.83-1.04, P=0.187), AA=reference]. Conclusions: Significant racial disparity in incidence and survival for GIST exists, and efforts should be made to bridge this gap and improve outcomes for all races. [Table: see text]
PARTIAL ANOMALOUS PULMONARY VENOUS RETURN WITH INTACT ATRIAL SEPTUM: A RARE CAUSE OF PULMONARY ARTERIAL HYPERTENSION
Authors: Bryan E-Xin Tan, Jian Liang Tan, Mamta Chhabria, Naman Sharma, Pui Yen Wong, Ming-Yan Chow
Journal: Journal of the American College of Cardiology (2020)
EFFECTIVENESS OF A WEIGHT LOSS PROGRAM USING DIGITAL HEALTH IN TEENS AND PRETEENS AN OBSERVATIONAL STUDY OF 2,825 ADOLESCENTS
Authors: Sha Lei, Christopher Scott, Amir Lerman, Jose Medina-Inojosa, Lilach Lerman, Mariza de Andrade, Conor Senecal, Francisco Lopez-Jimemez
Journal: Journal of the American College of Cardiology (2020)
COMPLETE FOUR CHAMBER RESYNCHRONIZATION VIA NOVEL PERCUTANEOUS EPICARDIAL PACING LEAD
Authors: Martin van Zyl, Omar Ziad Yasin, Adetola Ladejobi, Vaibhav Vaidya, Alan Sugrue, Noah Schneider, Roshini Asirvatham, Jason Tri, Paul Friedman, Samuel Asirvatham
Journal: Journal of the American College of Cardiology (2020)
冠動脈三枝病変および左主幹冠動脈疾患患者における冠動脈バイパス移植術と経皮的冠動脈形成術の比較:無作為,臨床SYNTAX試験の5年の追跡調査
Authors: W Mohr Friedrich, Morice Marie-Claude, Kappetein A. Pieter, W Serruys Patrick, E Feldman Ted, Stahle Elisabeth, Colombo Antonio, J Mack Michael, Holmes David R., Morel Marie-Angele, Van Dyck Nic, M Houle Vicki, D Dawkins Keith
Journal: The Lancet (2013)
ASSOCIATION OF HABITUAL PHYSICAL ACTIVITY WITH HOME BLOOD PRESSURE: INSIGHTS FROM THE ELECTRONIC FRAMINGHAM HEART STUDY
Authors: Mayank Sardana, Honghuang Lin, Ludovic Trinquart, Yuankai Zhang, Chunyu Liu, Emelia Benjamin, Emily Manders, Kelsey Fusco, Jelena Kornej, Michael Hammond, Nicole Spartano, Vik Kheterpal, Chris Nowak, Joanne Murabito, David McManus
Journal: Journal of the American College of Cardiology (2020)